MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
0.732
+0.012 (1.71%)
At close: Nov 6, 2024, 4:00 PM
0.748
+0.015 (2.08%)
Pre-market: Nov 7, 2024, 7:26 AM EST
MiNK Therapeutics Employees
MiNK Therapeutics had 31 employees as of December 31, 2023. The number of employees decreased by 6 or -16.22% compared to the previous year.
Employees
31
Change (1Y)
-6
Growth (1Y)
-16.22%
Revenue / Employee
n/a
Profits / Employee
-$551,289
Market Cap
28.95M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 31 | -6 | -16.22% |
| Dec 31, 2022 | 37 | 4 | 12.12% |
| Dec 31, 2021 | 33 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Bionano Genomics | 344 |
| DarioHealth | 294 |
| Precision Optics Corporation | 85 |
| BioXcel Therapeutics | 74 |
| IGC Pharma | 67 |
| Movano | 30 |
| NeuroOne Medical Technologies | 16 |
INKT News
- 6 days ago - MiNK Therapeutics Announces Appointment of Dr. Robert Kadlec to Board of Directors - GlobeNewsWire
- 4 weeks ago - MiNK Therapeutics and Autonomous Therapeutics Announce Collaboration to Develop Novel Therapies Targeting Metastatic Tumors - GlobeNewsWire
- 4 weeks ago - MiNK Therapeutics to Present Data From iNKT Cell Programs at SITC 2024 - GlobeNewsWire
- 2 months ago - MiNK Therapeutics to Participate in H.C. Wainwright Global Investment Conference - GlobeNewsWire
- 3 months ago - MiNK Therapeutics, Inc. (INKT) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - MiNK Reports Second Quarter 2024 Results and Business Update - GlobeNewsWire
- 3 months ago - MiNK Therapeutics to Provide Corporate Update and Second Quarter 2024 Financial Report - GlobeNewsWire
- 3 months ago - MiNK Therapeutics Regains Compliance with Nasdaq Capital Market Requirement - GlobeNewsWire